Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CSL ( (AU:CSL) ) just unveiled an announcement.
CSL Limited has announced its upcoming Capital Markets Day event, scheduled for November 4-5, 2025, in Chicago, Illinois. The event will feature presentations on the company’s business activities and growth initiatives, with live webcasts available for the initial session and recordings accessible afterward. This event is expected to provide insights into CSL’s strategic direction and operational plans, potentially impacting investor perceptions and market positioning.
The most recent analyst rating on (AU:CSL) stock is a Buy with a A$225.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited is a global biotechnology company that specializes in developing and delivering innovative medicines for people with rare and serious diseases. The company is focused on providing life-saving products and services in the biopharmaceutical industry.
YTD Price Performance: -35.35%
Average Trading Volume: 1,325,144
Technical Sentiment Signal: Sell
Current Market Cap: A$86.6B
For a thorough assessment of CSL stock, go to TipRanks’ Stock Analysis page.